# One Health Company

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/one-health-company

- Industry: Biotechnology
- Headquarters: Palo Alto, US
- Website: www.fidocure.com
- Total disclosed funding: $16M
- Latest round: Series A (Oct 29, 2020)
- Investors on record: 9

## About

One Health Company, Inc. focuses on precision medicine for canine cancer, utilizing genomic testing to provide targeted therapy recommendations that enhance treatment effectiveness and improve outcomes for pets.Founded in 2016 and headquartered in Palo Alto, US, One Health Company, Inc. specializes in innovative solutions for canine cancer treatment. The company has completed 6 deals, with its most recent deal occurring on July 19, 2022. The Series A funding round raised USD 10.00 mn, led by Borealis Ventures and Polaris Partners, with participation from notable investors such as Andreessen Horowitz, Lerer Hippeau Ventures, TAU Ventures, and Y Combinator. The company was established by founders Benjamin Lewis, Christina Lopes, and Ravi Tolwani, with Christina Lopes serving as CEO.One Health Company, Inc., through its FidoCure platform, provides precision medicine specifically for canine cancer treatment. This includes genomic testing and tailored therapy recommendations based on genetic mutations linked to tumors in dogs. Veterinarians utilize these insights to create personalized treatment plans that aim to optimize efficacy beyond standard chemotherapy and radiation. The solutions are primarily accessed by veterinary clinics across North America, particularly in the growing market of advanced veterinary oncology services in the United States.One Health Company, Inc. generates revenue by engaging directly with veterinary clinics that use its genomic testing and targeted therapy recommendations for treating canine cancer. The company's business model includes fee-for-service transactions, where veterinarians leverage genetic test results to prescribe treatments, which may involve compounded therapies from partner pharmacies. Their flagship product, FidoCure®, is central to their offerings, supporting veterinarians in cancer treatment protocols while establishing robust partnerships within the veterinary sector.In July 2022, One Health Company, Inc. secured venture funding from Global Brain, which will provide additional growth opportunities. The company plans to expand its market presence and product offerings, although specific details on new products or geographical expansion timelines have not been disclosed. The recent funding is expected to support these strategic initiatives and enhance their service capabilities.

## Funding rounds

- Series A, Oct 29, 2020, $10M — Polaris Partners, Borealis Ventures, Andreessen Horowitz, Lerer Hippeau Ventures, Y Combinator, TAU Ventures
- Seed, Jan 23, 2019, $5M — Andreessen Horowitz, Lerer Hippeau Ventures, Y Combinator
- Seed, Jun 10, 2018 — M Ventures
- Seed, Jan 4, 2018, $0.1M — Y Combinator
- Seed, Jun 10, 2016, $1.3M — Rittenhouse Ventures, BioAdvance

## Investors

- Rittenhouse Ventures (https://capitalatlas.ai/funds/rittenhouse-ventures) — Seed
- BioAdvance (https://capitalatlas.ai/funds/bioadvance) — Seed
- Y Combinator (https://capitalatlas.ai/funds/y-combinator) — Seed, Series A
- M Ventures (https://capitalatlas.ai/funds/m-ventures) — Seed
- Andreessen Horowitz (https://capitalatlas.ai/funds/andreessen-horowitz) — Seed, Series A
- Lerer Hippeau Ventures — Seed, Series A
- Polaris Partners (https://capitalatlas.ai/funds/polaris-partners) — Series A
- Borealis Ventures (https://capitalatlas.ai/funds/borealis-ventures) — Series A
- TAU Ventures — Series A